Gavi
Latest
U.S. Retreat from Gavi Cedes Influence to China's Vaccine Suppliers
The loss of U.S. funding could leave Gavi with three options to downsize its operations
A New Way to Drive COVID-19 Vaccine Development
How a "benefit-based advance market commitment" could build on existing Gavi COVAX and EU Joint Procurement initiatives